<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39380590</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1806-9339</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia</Title><ISOAbbreviation>Rev Bras Ginecol Obstet</ISOAbbreviation></Journal><ArticleTitle>Neonatal and maternal outcomes of mRNA versus Non-mRNA COVID-19 vaccines in pregnant patients: a systematic review and meta-analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e-rbgo69</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.61622/rbgo/2024rbgo69</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To compare the effectiveness and safety of non-mRNA versus mRNA COVID-19 vaccines on pregnant women and their newborns in a systematic review with meta-analysis.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="UNASSIGNED">We searched PubMed, Embase, and Cochrane Central in May 2023.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="UNASSIGNED">The search strategy yielded 4451 results, 16 studies were fully reviewed. We selected case-control studies analysing non-mRNA versus mRNA vaccines. Data collection and analysis: we assessed the risk of bias using the Cochrane Risk of Bias in Non-randomized Studies of Interventions (ROBINS-I) tool. Standardised mean differences were pooled using random-effect models.</AbstractText><AbstractText Label="DATA SYNTHESIS" NlmCategory="UNASSIGNED">We identified 8 prospective and retrospective studies with a total of 32,153 patients. Non-mRNA vaccines were associated with a higher incidence of fever (OR 2.67; 95% CI 2.08-3.43; p&lt;0.001), and a lower incidence of fetal or neonatal death (OR 0.16; 95% CI 0.08-0.33; p&lt;0.001). In subgroup analyses, the Jansen vaccine (Ad26.COV2.S) was found to have a higher rate of premature labor/delivery (OR 4.48; 95% CI 1.45-13.83; p=0.009) and missed/spontaneous abortion (OR 1.90; 95% CI 1.09-3.30; p=0.02), as compared with the Pfizer (BNT162b2) vaccine.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">non-mRNA vaccines are associated with a lower incidence of fetal or neonatal death among pregnant women who receive a Covid19 vaccine, although at an increased rate of pyrexia compared with mRNA vaccines. Other studies are required for better assessment.</AbstractText><AbstractText Label="PROSPERO" NlmCategory="UNASSIGNED">CRD42023421814.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Juliana Almeida</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0002-4704-2318</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Minas Gerais Belo HorizonteMG Brazil Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Eloisa Gonçalves</ForeName><Initials>EG</Initials><Identifier Source="ORCID">0000-0002-8243-4464</Identifier><AffiliationInfo><Affiliation>Centro Universitário de Jaguariúna JaguariúnaSP Brazil Centro Universitário de Jaguariúna, Jaguariúna, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karasu</LastName><ForeName>Ayse Filiz Gokmen</ForeName><Initials>AFG</Initials><Identifier Source="ORCID">0000-0001-7480-4691</Identifier><AffiliationInfo><Affiliation>Bezmialem Vakif University Istanbul Turkey Obstetrician and Gynecologist, Bezmialem Vakif University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Anelise Maria Nicolau</ForeName><Initials>AMN</Initials><Identifier Source="ORCID">0009-0007-5740-9500</Identifier><AffiliationInfo><Affiliation>Escola Bahiana de Medicina e Saúde Pública SalvadorBA Brazil Escola Bahiana de Medicina e Saúde Pública, Salvador, BA, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Philip</LastName><ForeName>Chris Elizabeth</ForeName><Initials>CE</Initials><Identifier Source="ORCID">0009-0001-4375-9522</Identifier><AffiliationInfo><Affiliation>Beaumont hospital Dublin Ireland Obstetrician and Gynecologist, Beaumont hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Rev Bras Ginecol Obstet</MedlineTA><NlmUniqueID>9214757</NlmUniqueID><ISSNLinking>0100-7203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000087503">mRNA Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000087503" MajorTopicYN="Y">mRNA Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="Y">Pregnancy Complications, Infectious</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="N">Pregnancy Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 vaccines</Keyword><Keyword MajorTopicYN="N">Coronavirus infections</Keyword><Keyword MajorTopicYN="N">Infant, newborn</Keyword><Keyword MajorTopicYN="N">Pregnancy complications</Keyword><Keyword MajorTopicYN="N">Pregnant women</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">mRNA vaccines</Keyword></KeywordList><CoiStatement>Conflicts to interest: none to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>4</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39380590</ArticleId><ArticleId IdType="pmc">PMC11460421</ArticleId><ArticleId IdType="doi">10.61622/rbgo/2024rbgo69</ArticleId><ArticleId IdType="pii">e-rbgo69</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, et al. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(44):1641–1647. doi: 10.15585/mmwr.mm6944e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6944e3</ArticleId><ArticleId IdType="pmc">PMC7643892</ArticleId><ArticleId IdType="pubmed">33151921</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvert C, Carruthers J, Denny C, Donaghy J, Hopcroft LE, Hopkins L, et al. A population-based matched cohort study of major congenital anomalies following COVID-19 vaccination and SARS-CoV-2 infection. 107Nat Commun. 2023;14(1) doi: 10.1038/s41467-022-35771-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-35771-8</ArticleId><ArticleId IdType="pmc">PMC9821346</ArticleId><ArticleId IdType="pubmed">36609574</ArticleId></ArticleIdList></Reference><Reference><Citation>Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: The INTERCOVID Multinational Cohort Study. Obstet Gynecol Surv. 2022;77(2):80–82. doi: 10.1097/01.ogx.0000816508.60579.d5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ogx.0000816508.60579.d5</ArticleId><ArticleId IdType="pmc">PMC8063132</ArticleId><ArticleId IdType="pubmed">33885740</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ. 2021;193(16):E540–E548. doi: 10.1503/cmaj.202604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.202604</ArticleId><ArticleId IdType="pmc">PMC8084555</ArticleId><ArticleId IdType="pubmed">33741725</ArticleId></ArticleIdList></Reference><Reference><Citation>Collier AY, McMahan K, Yu J, Tostanoski LH, Aguayo R, Ansel J, et al. Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women. JAMA. 2021;325(23):2370–2380. doi: 10.1001/jama.2021.7563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.7563</ArticleId><ArticleId IdType="pmc">PMC8120446</ArticleId><ArticleId IdType="pubmed">33983379</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray KJ, Bordt EA, Atyeo C, Deriso E, Akinwunmi B, Young N, et al. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol. 2021;225(3):303.e1–303e17. doi: 10.1016/j.ajog.2021.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2021.03.023</ArticleId><ArticleId IdType="pmc">PMC7997025</ArticleId><ArticleId IdType="pubmed">33775692</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy AT, Singh S, Riley LE, Prabhu M. Acceptance of COVID-19 vaccination in pregnancy: a survey study. Am J Obstet Gynecol MFM. 2021;3(5):100399. doi: 10.1016/j.ajogmf.2021.100399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajogmf.2021.100399</ArticleId><ArticleId IdType="pmc">PMC8129996</ArticleId><ArticleId IdType="pubmed">34020098</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsel C, Moniz MH, Wagner AL, Zikmund-Fisher BJ, Hawley S, Jiang L, et al. COVID-19 vaccine hesitancy among reproductive-aged female tier 1A healthcare workers in a United States Medical Center. J Perinatol. 2021;41(10):2549–2551. doi: 10.1038/s41372-021-01173-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41372-021-01173-9</ArticleId><ArticleId IdType="pmc">PMC8424167</ArticleId><ArticleId IdType="pubmed">34497336</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahlers-Schmidt CR, Hervey AM, Neil T, Kuhlmann S, Kuhlmann Z. Concerns of women regarding pregnancy and childbirth during the COVID-19 pandemic. Patient Educ Couns. 2020;103(12):2578–2582. doi: 10.1016/j.pec.2020.09.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2020.09.031</ArticleId><ArticleId IdType="pmc">PMC7515599</ArticleId><ArticleId IdType="pubmed">33010997</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad S, Kalafat E, Blakeway H, Townsend R, O'Brien P, Morris E, et al. Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy. 2414Nat Commun. 2022;13(1) doi: 10.1038/s41467-022-30052-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30052-w</ArticleId><ArticleId IdType="pmc">PMC9090726</ArticleId><ArticleId IdType="pubmed">35538060</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Deng J, Liu Q, Du M, Liu M, Liu J. Effectiveness and safety of COVID-19 vaccine among pregnant women in real-world studies: a systematic review and meta-analysis. 246Vaccines. 2022;10(2) doi: 10.3390/vaccines10020246.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10020246</ArticleId><ArticleId IdType="pmc">PMC8879911</ArticleId><ArticleId IdType="pubmed">35214704</ArticleId></ArticleIdList></Reference><Reference><Citation>Hameed I, Khan MO, Nusrat K, Mahmood S, Nashit M, Malik S, et al. Is it safe and effective to administer COVID-19 vaccines during pregnancy? A systematic review and meta-analysis. Am J Infect Control. 2023;51(5):582–593. doi: 10.1016/j.ajic.2022.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajic.2022.08.014</ArticleId><ArticleId IdType="pmc">PMC9394101</ArticleId><ArticleId IdType="pubmed">36007670</ArticleId></ArticleIdList></Reference><Reference><Citation>Galanis P, Vraka I, Siskou O, Konstantakopoulou O, Katsiroumpa A, Kaitelidou D. Uptake of COVID-19 vaccines among pregnant women: a systematic review and meta-analysis. 766Vaccines. 2022;10(5) doi: 10.3390/vaccines10050766.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10050766</ArticleId><ArticleId IdType="pmc">PMC9145279</ArticleId><ArticleId IdType="pubmed">35632521</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagrass AI, Almadhoon HW, Al-Kafarna M, Almaghary BK, Nourelden AZ, Fathallah AH, et al. Maternal and neonatal safety outcomes after SAR-CoV-2 vaccination during pregnancy: a systematic review and meta-analysis. 581BMC Pregnancy Childbirth. 2022;22(1) doi: 10.1186/s12884-022-04884-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12884-022-04884-9</ArticleId><ArticleId IdType="pmc">PMC9302221</ArticleId><ArticleId IdType="pubmed">35864455</ArticleId></ArticleIdList></Reference><Reference><Citation>Tormen M, Taliento C, Salvioli S, Piccolotti I, Scutiero G, Cappadona R, et al. Effectiveness and safety of COVID-19 vaccine in pregnant women: a systematic review with meta-analysis. BJOG. 2023;130(4):348–357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9878107</ArticleId><ArticleId IdType="pubmed">36444098</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding C, Liu Y, Pang W, Zhang D, Wang K, Chen Y. Associations of COVID-19 vaccination during pregnancy with adverse neonatal and maternal outcomes: a systematic review and meta-analysis. 1044031Front Public Health. 2023;11 doi: 10.3389/fpubh.2023.1044031.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1044031</ArticleId><ArticleId IdType="pmc">PMC9922836</ArticleId><ArticleId IdType="pubmed">36794075</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciapponi A, Berrueta M, Parker E, Bardach A, Mazzoni A, Anderson SA, et al. Safety of COVID-19 vaccines during pregnancy: a systematic review and meta-analysis. Vaccine. 2023;41(25):3688–3700. doi: 10.1016/j.vaccine.2023.03.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.03.038</ArticleId><ArticleId IdType="pmc">PMC10040368</ArticleId><ArticleId IdType="pubmed">37012114</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. 89Syst Rev. 2021;10(1) doi: 10.1186/s13643-021-01626-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-021-01626-4</ArticleId><ArticleId IdType="pmc">PMC8008539</ArticleId><ArticleId IdType="pubmed">33781348</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hernán MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016:i4919. doi: 10.1136/bmj.i4919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4919</ArticleId><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob-Chow B, Vasundhara KL, Cheang HK, Low JM, Amin Z. Reactogenicity of mRNA- and Non-mRNA-base COVID-19 vaccines among lactating mother and child dyads. 1094Vaccines. 2022;10(7) doi: 10.3390/vaccines10071094.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10071094</ArticleId><ArticleId IdType="pmc">PMC9320631</ArticleId><ArticleId IdType="pubmed">35891258</ArticleId></ArticleIdList></Reference><Reference><Citation>Kant A, Jansen J, van Balveren L, van Hunsel F. Description of frequencies of reported adverse events following immunizations among four different COVID-19 vaccine brads. Drug Saf. 2022;45(4):319–331. doi: 10.1007/s40264-022-01151-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-022-01151-w</ArticleId><ArticleId IdType="pmc">PMC8936041</ArticleId><ArticleId IdType="pubmed">35314943</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi CD, Port VB, Nóbrega ME, Cabral MC, Barros TD, Martins DM. Adverse events related to COVID-19 vaccines reported in pregnant women in Brazil. Rev Bras Ginecol Obstet. 2022;44(9):821–829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9948040</ArticleId><ArticleId IdType="pubmed">36067796</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnus MC, Ortqvist AK, Dahlqwist E, Ljung R, Skar F, Oakley L, et al. Association of SARS-CoV-2 vaccination during pregnancy with pregnancy outcomes. JAMA. 2022;37(15):1469–1477. doi: 10.1001/jama.2022.3271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.3271</ArticleId><ArticleId IdType="pmc">PMC8949721</ArticleId><ArticleId IdType="pubmed">35323851</ArticleId></ArticleIdList></Reference><Reference><Citation>Mascolo A, di Mauro G, Fraenza F, Gaio M, Zinzi A, Pentella C, et al. Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: the preg-co-vax study. 965171Front Immunol. 2022;13 doi: 10.3389/fimmu.2022.965171.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.965171</ArticleId><ArticleId IdType="pmc">PMC9574088</ArticleId><ArticleId IdType="pubmed">36263025</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao Y, Abreu AJ, Dias CZ, Meng X, Ferreira RV, Pereira RG, et al. Safety profile of COVID-19 vaccines in pregnant and postpartum women in Brazil. MedRXIV. 2021 doi: 10.1101/2021.12.14.21267777. Preprint.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.12.14.21267777</ArticleId></ArticleIdList></Reference><Reference><Citation>Vuong LN, Chau MN, Nguyen DL, Pham TD, Mol BW, Tuong MH. COVID-19 vaccination in pregnancy: experience in Viet Nam. Eur J Obstet Gynecol Reprod Biol. 2022;274:251–252. doi: 10.1016/j.ejogrb.2022.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejogrb.2022.05.008</ArticleId><ArticleId IdType="pmc">PMC9106409</ArticleId><ArticleId IdType="pubmed">35597722</ArticleId></ArticleIdList></Reference><Reference><Citation>Badell ML, Dude CM, Rasmussen SA, Jamieson DJ. Covid-19 vaccination in pregnancy. BMJ. 2022;378:e069741. doi: 10.1136/bmj-2021-069741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069741</ArticleId><ArticleId IdType="pmc">PMC9363819</ArticleId><ArticleId IdType="pubmed">35948352</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu N, Joyal-Desmarais K, Ribeiro PA, Vieira AM, Stojanovic J, Sanuade C, et al. Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. Lancet Respir Med. 2023;11(5):439–452. doi: 10.1016/S2213-2600(23)00015-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00015-2</ArticleId><ArticleId IdType="pmc">PMC9917454</ArticleId><ArticleId IdType="pubmed">36780914</ArticleId></ArticleIdList></Reference><Reference><Citation>Mewada BN, Gandhi D, Diwan F, Panchal PN. Prospective study of pyrexia with pregnancy. Ann Afr Med. 2023;22(1):1–4. doi: 10.4103/aam.aam_75_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/aam.aam_75_20</ArticleId><ArticleId IdType="pmc">PMC10064890</ArticleId><ArticleId IdType="pubmed">36695215</ArticleId></ArticleIdList></Reference><Reference><Citation>Citu IM, Citu C, Gorun F, Sas I, Bratosin F, Motoc A, et al. The risk of spontaneous abortion does not increase following first trimester mRNA COVID-19 vaccination. 1698J Clin Med. 2022;11(6) doi: 10.3390/jcm11061698.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11061698</ArticleId><ArticleId IdType="pmc">PMC8955378</ArticleId><ArticleId IdType="pubmed">35330023</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>